Principal Scientist, Molecular Discovery @ Epizyme (January 2011 - September 2013)
Manager, Discovery Chemistry @ Antisoma (June 2008 - December 2010)
Senior Scientist @ Xanthus Pharmaceuticals (Acquired by Antisoma) (November 2006 - May 2008)
Research Chemist @ (June 2006 - November 2006)
Research Scientist @ Cyclacel Pharmaceuticals, Inc. (November 2001 - December 2005)
Associate Scientist @ Solvay Interox (March 1996 - May 1997)
Kenneth Duncan Education
University of Strathclyde
PhD (Chemistry)
1998-2001
University of Strathclyde
BSc (Hons) (Chemistry)
1993-1998
Kenneth Duncan Skills
Drug Discovery
Program Management
Molecular Modeling
Technical Writing
Oncology
Chemistry
Clinical Development
CRO
Drug Design
In Vivo
Organic Chemistry
Medicinal Chemistry
Lifesciences
Technology Transfer
Organic Synthesis
Drug Development
Research
Molecular
Wood
Project Management
Strategy
Kenneth Duncan Summary
Kenneth Duncan, based in United States, is currently a SVP, Chemistry at Stealth Mode Biotech. Kenneth Duncan brings experience from previous roles at KDDiscovery LLC., Accent Therapeutics, Inc. and Epizyme. Kenneth Duncan holds a 1998 - 2001 PhD in Chemistry @ University of Strathclyde. With a robust skill set that includes Drug Discovery, Program Management, Molecular Modeling, Technical Writing, Oncology and more. Kenneth Duncan has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Kenneth Duncan?
Find contact details for 700 million professionals.